New Delhi: Drug firm Lupin today said it has received US health regulator`s approval to market its generic Lorazepam Oral Concentrate, used for treating anxiety disorders, in the American market. Lupin Pharmaceuticals Inc, a subsidiary of Lupin, has received final approval from US Food and Drug Administration (USFDA) for its Lorazepam Oral Concentrate USP, Lupin Ltd said in a statement.
Tejas closer to induction into IAF
No plans to drop charges against Khobragade: US
`Dhoom 3` audience verdict
Lieutenant Governor Najeeb Jung recommends President`s rule in Delhi